Page last updated: 2024-08-24

suberosin and Alloxan Diabetes

suberosin has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Iqbal, S; Jabeen, F; Kahwa, I; Omara, T	1

Other Studies

1 other study(ies) available for suberosin and Alloxan Diabetes

Article	Year
Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways. Cardiovascular toxicology, 2023, Volume: 23, Issue:9-10 Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Animals; Cardiomyopathies; Coumarins; Diabetes Mellitus, Experimental; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazolidinediones	2023

Article

Year

Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways.

Cardiovascular toxicology, 2023, Volume: 23, Issue:9-10

Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Animals; Cardiomyopathies; Coumarins; Diabetes Mellitus, Experimental; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazolidinediones

2023